In addition, when ovarian cancer cells are treated with a hedgehog inhibitor, cyclopamine, and Gli1 siRNA, the anoikis resistance can be significantly reduced, substantiating that Gli1 is a key protein in the induction of anoikis in ovarian cancer [283]. The gene discussed is GLI1; the disease is ovarian carcinoma.